100 related articles for article (PubMed ID: 11950273)
1. Oxidative damage to nucleic acids in human prion disease.
Guentchev M; Siedlak SL; Jarius C; Tagliavini F; Castellani RJ; Perry G; Smith MA; Budka H
Neurobiol Dis; 2002 Apr; 9(3):275-81. PubMed ID: 11950273
[TBL] [Abstract][Full Text] [Related]
2. Redox metals and oxidative abnormalities in human prion diseases.
Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
[TBL] [Abstract][Full Text] [Related]
3. Increased oxidation, glycoxidation, and lipoxidation of brain proteins in prion disease.
Pamplona R; Naudí A; Gavín R; Pastrana MA; Sajnani G; Ilieva EV; Del Río JA; Portero-Otín M; Ferrer I; Requena JR
Free Radic Biol Med; 2008 Oct; 45(8):1159-66. PubMed ID: 18703134
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species.
Díaz-San Segundo F; Salguero FJ; de Avila A; Espinosa JC; Torres JM; Brun A
Acta Neuropathol; 2006 Nov; 112(5):587-95. PubMed ID: 16957924
[TBL] [Abstract][Full Text] [Related]
5. Regional and phenotype heterogeneity of cellular prion proteins in the human brain.
Kuczius T; Koch R; Keyvani K; Karch H; Grassi J; Groschup MH
Eur J Neurosci; 2007 May; 25(9):2649-55. PubMed ID: 17466020
[TBL] [Abstract][Full Text] [Related]
6. Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases.
Kovacs GG; Voigtländer T; Hainfellner JA; Budka H
Acta Neuropathol; 2002 Sep; 104(3):320-6. PubMed ID: 12172919
[TBL] [Abstract][Full Text] [Related]
7. The octarepeat region of prion protein, but not the TM1 domain, is important for the antioxidant effect of prion protein.
Malaisé M; Schätzl HM; Bürkle A
Free Radic Biol Med; 2008 Dec; 45(12):1622-30. PubMed ID: 18824094
[TBL] [Abstract][Full Text] [Related]
8. Understanding the natural variability of prion diseases.
Geissen M; Krasemann S; Matschke J; Glatzel M
Vaccine; 2007 Jul; 25(30):5631-6. PubMed ID: 17391814
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
[TBL] [Abstract][Full Text] [Related]
10. Elevated manganese levels in blood and CNS in human prion disease.
Hesketh S; Sassoon J; Knight R; Brown DR
Mol Cell Neurosci; 2008 Mar; 37(3):590-8. PubMed ID: 18234506
[TBL] [Abstract][Full Text] [Related]
11. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
Manuelidis L
J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
[TBL] [Abstract][Full Text] [Related]
12. A manganese-superoxide dismutase/catalase mimetic extends survival in a mouse model of human prion disease.
Brazier MW; Doctrow SR; Masters CL; Collins SJ
Free Radic Biol Med; 2008 Jul; 45(2):184-92. PubMed ID: 18455516
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of cerebral neurodegeneration in prion diseases.
Tatzelt J; Schätzl HM
FEBS J; 2007 Feb; 274(3):606-11. PubMed ID: 17288549
[TBL] [Abstract][Full Text] [Related]
14. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
15. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
16. Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease.
Vogelgesang S; Glatzel M; Walker LC; Kroemer HK; Aguzzi A; Warzok RW
Acta Neuropathol; 2006 May; 111(5):436-43. PubMed ID: 16523342
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
18. From cell protection to death: may Ca2+ signals explain the chameleonic attributes of the mammalian prion protein?
Sorgato MC; Bertoli A
Biochem Biophys Res Commun; 2009 Feb; 379(2):171-4. PubMed ID: 19101513
[TBL] [Abstract][Full Text] [Related]
19. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
Zaborowski A
Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
[TBL] [Abstract][Full Text] [Related]
20. Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.
Brazier MW; Lewis V; Ciccotosto GD; Klug GM; Lawson VA; Cappai R; Ironside JW; Masters CL; Hill AF; White AR; Collins S
Brain Res Bull; 2006 Jan; 68(5):346-54. PubMed ID: 16377442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
